<DOC>
	<DOCNO>NCT02180451</DOCNO>
	<brief_summary>The purpose study characterize circadian rhythm disruption experience patient determined plasma melatonin , cortisol , circadian analytes</brief_summary>
	<brief_title>Observational Study Investigate Melatonin Cortisol Circadian Rhythms Individuals With Smith-Magenis Syndrome ( SMS )</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Smith-Magenis Syndrome</mesh_term>
	<mesh_term>Hydrocortisone</mesh_term>
	<mesh_term>Melatonin</mesh_term>
	<criteria>A confirmed clinical diagnosis SMS prior positive genetic test result indicate parent/guardian Informed consent patient legal guardian/assent provide individual SMS , possible Male female age 650 year age History sleep disturbance Willing able comply study requirement restriction Failure confirm diagnosis SMS molecular cytogenetic method and/or DNAbased mutation analysis RAI1 gene Totally blind light perception Institutionalized living assist living facility Unwilling unable follow medication restriction ( medication affect sleep melatonin secretion ) unwilling unable sufficiently washout use restrict medication Any medical condition , determine clinical investigator would make unsafe blood draw ( e.g. , anemia , blood clotting disorder , anxiety , etc . ) Any sound medical reason determine clinical investigator</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>March 2016</verification_date>
</DOC>